ABSTRACT Heparan sulfate glycosaminoglycan, isolated from the cell surface of nonadhering murine myeloma cells (P3X63-Ag8653), does not bind to plasma fibronectin, but binds partially to collagen type I, as assayed by affinity chromatography with proteins immobilized on cyanogen bromideactivated Sepharose 4B. Identical results were obtained when myeloma heparan sulfate was cochromatographed, on the same fibronectin and collagen columns, with cell surface heparan sulfates from adhering Swiss mouse 3T3 and SV3T3 cells. These latter heparan sulfates do, however, bind to both fibronectin and collagen, as reported earlier (Stamatoglou, S. C., and J. M. Keller, 1981, Biochim. Biophys. Acta., 719:90-97). Cell adhesion assays established that hydrated collagen substrata can support myeloma cell attachment, but fibronectin cannot. Saturation of the heparan sulfate binding sites on the collagen substrata with heparan sulfate or heparin, prior to cell inoculation, abolished the ability to support cell adhesion, whereas chondroitin 4 sulfate, chondroitin 6 sulfate, and hyaluronic acid had no effect.
Cell surface heparan sulfate is a ubiquitous cell surface proteogiycan (1) believed to be attached to the plasma membrane via a hydrophobic region in the proteoglycan core protein (2) (3) (4) . Enrichment of cell-substrate adhesion sites with heparan sulfate (5, 6 ) and binding of cell surface heparan sulfate to extracellular adhesive proteins such as fibronectin (7, 8) and coUageu (8) suggest an involvement in ceU adhesion. On the basis of this suggestion we predict that some nonadhering ceUs might either lack this cell surface molecule or have structurally altered ceil surface heparan sulfate with no affinity for adhesive matrices. In this study we used nonadh.ering myeloma cells to demonstrate a correlation between ceil surface heparan sulfate affinity for collagen or fibronectin and cellular attachment to collagen or fibronectin substrata. That these cells do not adhere in vitro facilitated our adhesion assays since no enzymatic treatment (which would remove cell surface molecules) was required to produce single-cell suspensions. Furthermore, plasma cells are not known to produce any extracellular collagenous matrices, which could interfere with the results. [6- (N)3H]giucosamine), cyanogen bromide (CNBr)-activated Sepharose 4B, Hepes, collagen, reference standard chondroitin 4 sulfate, chondroitin 6 sulfate, heparin, and hyalaronic acid were obtained from sources mentioned in an earlier report (8) . [Methyl.3H]thymidine was purchased from New England Nuclear, Boston, MA. Heparan sulfate, a gift from Dr. K. L. Keller (Chicago Medical School, North Chicago, IL), was purified from a crude heparan sulfate preparation from Upjohn Co. (Kalamazoo, MI) according to established procedures (9, 10).
MATERIALS AND METHODS

Materials: Radioisotopes (H2. ~5SO4, D-[ 1-14C]giucosamine, D-
Cell Cultures: The P3X63-Ag8653 line of murine myeloma cells was obtained from the Institute of Medical Research (Camden, NJ) and maintained in Dulbecco-Vogt medium (1 l), supplemented with 10% fetal bovine serum. The growth conditions for the Swiss mouse 3T3 and SV3T3 cells used in this laboratory have been described (12, 13) . (12, 14) use DEAE-cellulose ion exchange chromatography to isolate the giycosaminoglycans from pronasedigested cell surface trypsin extracts. The purified heparan sulfate is isolated on a second DEAE-cellulose column after degradation of contaminating chondroitin sulfate with chondroitin ABC lyase. Radiochemical purity of heparan sulfate was confirmed by nitrous acid degradation (1, 15) . The myeloma heparan sulfate glycosaminogiycan has a lower molecular weight, iduronic acid content, N-to Osulfate ratio, and charge density than either the 3T3 or SV3T3 heparan sulfate (16) .
Isolation of Radiolabeled Heparan
Fibronectin Isolation: Fibronectin was isolated from haman plasma on a gelatin/CNBr-activated Sepharose 4B affinity column (17) . Purity was confirmed by polyacrylamide slab gel electrophoresis (18) .
Affinity Chromatography: Affinity chromatography of heparan sulfate on protein-linked CNBr-activated Sepharose columns was performed as previously described (8) . The running buffer was 10 mM Hepes, and 150 mM NaCI (Hepes-saline), pH 6.50. Elution of bound material was effected with 2 M NaCI in the running buffer. As in previous experiments (8) , the recovery of radiolabeled material was >95%.
Preparation of Cell Culture Substrata: All substrata were prepared on 35 X 10-mm Falcon tissue culture dishes (Falcon Labware, Oxnard, CA). The preparation of hydrated collagen substrata was based on a published method (19) . A 3-mg/ml solution of calf skin collagen in 0.1% acetic acid was mixed with an equal volume of twice concentrated Hepes-saline and neutralized to pH 7.00. 700-pl aliquots of this solution were immediately dispensed into culture dishes and incubated at 37°C for 40 rain in a humidified incubator. Under these conditions collagen formed a lightly translucent gel. Its native conformation was confLrmed by identifying collagen t'zbrils with scanning electron microscopy of critical pint-dried samples.
Collagen substrata were treated with glycosaminoglycans (100 #g/dish for 30 rain at 37°C) in 1 ml of adhesion buffer (Hepes-saline, pH 6.50, 0.1% glucose, and 0.1% bovine serum albumin). This solution was then removed and 1 ml of adhesion buffer alone was added immediately prior to cell seeding. In preliminary studies we incubated collagen substrata with heparin solutions of various concentrations, and by uronic acid analyses (20) of nonbound heparin we established that 100/zg of heparin was sufficient to saturate the heparin-binding sites on the collagen. The collagen-coated dishes used for controls to glycosaminoglycan treatments were treated identically in the absence of glycosaminoglycans. Fibronectin-coated dishes were prepared by a 30-rain incubation 07°C) of dishes with 1 ml of ad3aesion buffer containing 100/~g fibronectin per dish. Dishes treated in this manner supported attachment of SV3T3 cells in adhesion buffer and induced enhanced spreading of the same ceils in serum-supplemented culture medium. Control dishes were incubated with 1 ml of adhesion buffer.
Adhesion Assay: Myeloma cells seeded at a density of los cells/ml were labeled after 24 h with [methyl.~H]thymidine (10 #Ci/ml). The ceils were grown in the presence of the isotope for another 20 h. Prior to the experiment the cells were collected by centrifugation, washed twice with Hepes-saEne, and resuspended in adhesion buffer. Cells were seeded to the appropriately treated dishes at a density of l0 s cells per 35 x 10 ram-dish, and the dishes were placed in an humidified incubator (adhesion at zero time was measured immediately after inoculation, i.e., without incubation). At specified intervals (10, 30, 60, 90 , and 120 rain) the nonattaehed cells were harvested from each dish by collecting the medium and rinsing each dish twice with Hepes-saline, and dissolved in Budget Solve (Research Products International Corp., Mr. Prospect, IL). Adherent ceils were dissolved in situ with 1 ml of 5% SDS and transferred to Budget Solve. All samples were counted in a Packard Tri-Carb liquid scintillation counter (Packard Instrument Co., Inc., Downers Grove, IL). The radioactivity remaining on the dish, expressed as a percentage of the total recovered radioactivity associated with adhering plus nonadhering cells, reflects the percentage of attaching cells. To preserve objectivity, duplicate experiments were carried out by different persons and the labels were coded.
RESULTS
Interactions of Myeloma Cell Surface Heparan Sulfate with Fibronectin and Collagen
Cell surface heparan sulfate isolated from myeloma cells was co-chromatographed with 3T3 and SV3T3 heparan sulfates on fibronectin and collagen immobilized on CNBr-activated Sepharose 4B. 3T3 and SV3T3 heparan sulfates bound to both fibronectin and collagen ( Fig. 1; [8] ), whereas myeloma heparan sulfate bound only to collagen (Fig. I b) . Lack of affmity for fibronectin and a ~35--45% binding to collagen were consistently demonstrated in repeated experiments using two different preparations of myeloma cell surface heparan sulfate. We observed no differences on these columns between myeloma heparan sulfate alone and myeloma heparan sulfate together with heparan sulfates from either 3T3 or SV3T3 cells. The partial binding of myeloma heparin sulfate to collagen indicated a heterogeneous molecular composition, and this was confirmed by re-chromatography of the collagen-binding fraction on collagen/Sepharose: Repeated binding could be demonstrated (Fig. I c) . The small amount of myeloma heparan sulfate adhering to the ftbronectin/CNBr-activated Sepharose 4B column was attributed to nonspeciflc interactions whose level (10%) was determined after chromatography of heparan sulfates on CNBr-activated Sepharose 4B derivatized in the absence of protein.
Interaction of Myeloma Cells with Fibronectin and Collagen Substrata In Vitro
Attachment of myeloma cells to the hydrated collagencoated dishes, but not to fibronectin-coated dishes, was observed (Fig. 2) . We followed the kinetics of adhesion for 120 rain, Most of the myeloma cells attached to the collagen substrata within 10 rain after inoculation, whereas adhesion to fibronectin-coated and control dishes remained close to background level (adhesion at zero time; Fig. 2) . Examination of the adhering cells with light microscopy indicated that the cells retained theft spherical shape, i.e., no spreading was detected.
Effect of Reference Standard Glycosaminoglycans on Myeloma Cell Adhesion to Collagen Substrata
In these experiments we examined the effect of saturating the heparan sulfate binding sites of the collagen substrata prior to the cell attachment assays. Reference standard heparan sulfate and heparin were used for this purpose and theft effect on cell adhesion is shown in Table I 
Time (rain)
Adhesion assay of myeloma cells on pretreated cell culture dishes. Myeloma cells labeled with [3H]thymidine were suspended in adhesion buffer (10 mM Hepes, 150 mM NaCI, pH 6.50, containing 0.1% glucose and 0.1% bovine serum albumin) and plated on dishes preincubated with collagen (0), fibronectin (A), or adhesion buffer alone (O). The actual method of substrata preparation and cell harvesting is described in Materials and Methods. The percentage of total radioactivity remaining on the culture dish is expressed as percentage of attaching cells.
reduced the number of adhering cells by >90%. To demonstrate speeiticity of inhibition we incubated collagen substrata with reference standard chondroitin 4 sulfate and chondroitin 6 sulfate (each of which possesses a charge density similar to that of heparan sulfate) and with hyaluronic acid. None of these glycosaminoglycans signiticantly affected cell attachment (Table I).
DISCUSSION
Myeloma cells and a sizable fraction of myeloma cell surface heparan sulfate bind to collagen but not to fibronectin. Saturation of the heparan sulfate binding sites on the collagen with heparan sulfate (or heparin) inhibited cell attachment to these collagen substrata. The data indicate that the myeloma cell surface receptor for adhesion-promoting collagen is heparan sulfate. Relevant to our findings is that some cell types are known to respond to collagen-mediated adhesion in the absence of fibronectin (19, 21, 22) . In addition, inhibition of cell attachment to substrate-attached material (SAM; [23] ) can be induced by preincubating this material with heparan sulfate or heparin (24) .
Our study corroborates accumulated evidence on cell surface heparan sulfate involvement in fibronectin-mediated adhesion of mesenchymal cells to extracellular matrices (5) (6) (7) (8) 24) : The heparan sulfate from the nonadhering myeloma cells does not bind to fibronectin nor can fibronectin support adhesion of these cells. However, at least in some cell types, the primary adhesion-determining cell receptor for fibronectin may not be heparan sulfate: A fibronectin domain that assures attachment of normal rat kidney cells in vitro does not contain the heparan sulfate binding site (25) . Additionally, a recent report has demonstrated that heparin does not block the attachment to or spreading on fibronectin by murine SVT2 cells (26) . Interestingly, although treatment of BALB c/3T3 cells with heparinase under conditions that removed >85% of the cell surface heparan sulfate did not prevent attachment to fibronectin, the spreading of these cells was greatly retarded, suggesting that the cell surface heparan sulfate is essential for the full spreading response of these cells (26) . The cell surface fibronectin receptors in these latter cases could be gangliosides (27) or a group of glycoproteins with Mr ~ 140,000 (28, 29) ; Cell surface heparan sulfates are structurally diverse molecules, and this diversity is related to the species and organ of origin (30) and to transformation (12, 14) . The latter is accompanied by a decrease in the O-to N-sulfate ratio (15, 31), which does not seem to affect the heparan sulfate affinity for either fibronectin or collagen (8) . In this report, however, a novel structure-function relationship is demonstrated. Heparan sulfate from the surface of nonadhering myeloma ceUs does not bind to fibronectin and is grossly different in structure compared with the fibronectin-binding heparan sulfates from adbering 3T3 and SV3T3 cells: Myeloma heparan sulfate (Mr ---25,000) is almost one-tenth the size of either 3T3 or SV3T3 heparan sulfate, and its iduronic acid content, N-to O-sulfate ratio, and charge density are, also, much lower (16) . So far, our studies indicate that N-sulfate and/or iduronic acid content may be important parameters in the heparan sulfate/fibronectin interactions (16) . Such interactions may be important not only in adhesion but also in forming extracellular matrices (32, 33) .
RAPID COMMUNICATIONS
In conclusion, we have shown that cell surface heparan sulfate can attach cells to collagen fibers. Similarly, other investigators have recently shown that cell surface heparan sulfate mediates attachment to a substrata of platelet factor 4 (26) . Our data also indicate a similar role for heparan sulfate in fibronectin-mediated adhesion, but this is a moot issue now in view of conflicting evidence. The myeloma heparan sulfate we used herein is the first reported heparan sulfate with no affinity for fibronectin. This observation serves to underline the heterogeneity of heparan sulfates and their potential importance in a variety of cellular functions.
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